A New Era of Immunotherapy in the Treatment of Locally Advanced Head and Neck Squamous Cell Carcinoma
The standard of care for locally advanced HNSCC has remained unchanged for decades. However, 2 landmark studies presented at the 2025 ASCO Annual Meeting may signal a pivotal shift in the management of locally advanced, resectable HNSCC. Key Points: The standard of care for locally advanced head and neck squamous cell carcinoma (HNSCC) has remained […]
HOW CAR-T CELLS ARE ENGINEERED TO FIGHT CANCER
HOW CAR-T CELLS ARE ENGINEERED TO FIGHT CANCER A chimeric antigen receptor (CAR) sprouts from the surface of a genetically reengineered white blood cell. The receptor is a manufactured protein, and designed by molecular biologists to seek out and interact with specific antigens appearing on cancer cells. Now empowered with CAR, these killer T-cells are […]
GIRL TREATED WITH CAR-T FOR NEUROBLASTOMA, IS STILL ALIVE AND HEALTHY 19 YEARS AFTER TREATMENT
GIRL TREATED WITH CAR-T FOR NEUROBLASTOMA, IS STILL ALIVE AND HEALTHY 19 YEARS AFTER TREATMENT In a recent study published in Nature Medicine, researchers report the successful treatment of a neuroblastoma patient with chimeric antigen receptor (CAR) T-cell therapy. A woman, now twenty-three years old and with two children, treated in 2006, with a pioneering […]